PhillipPerimanMD

PubMed

• 33 citations
  Randomized, phase II trial of pemetrexed and carboplatin with or without enzastaurin versus docetaxel and carboplatin as first-line treatment of patients with stage II...
  Mark A. Socinski, Robert N. Raju, Thomas E. Stinchcombe, Darren M. Kocs, Linda S. Couch, David Barrera, Steven R. Rousey, Janak K. Choksi, Robert M. Jotte, Debra A. Pa...> ;Journal of Thoracic Oncology. 2010 Dec 1
• 3 citations
  Reduced-intensity umbilical cord blood transplant for older adult patients.
  Seah H. Lim, William V. Esler, Phillip O. Periman, David Beggs, Yana Zhang, Mary Townsend> ;Bone Marrow Transplantation. 2008 Aug 18
• 5 citations
  R-CHOP followed by consolidative autologous stem cell transplant and low dose rituxan maintenance therapy for advanced mantle cell lymphoma.
  Seah H. Lim, William V. Esler, Phillip Periman, David Beggs, Yana Zhang, Mary Townsend> ;British Journal of Haematology. 2008 Aug 1
• Sunitinib malate for metastatic castration resistant prostate cancer following docetaxel-based chemotherapy.
  Periman PO, Sonpavde G, Bernold DM, Weckstein DJ, Williams A, Zhan F, Boehm KA, Asmar L, Hutson TE> ;J. Clin. Oncol.. 2008-05-20
• 33 citations
  B-cell depletion for 2 years after autologous stem cell transplant for NHL induces prolonged hypogammaglobulinemia beyond the rituximab maintenance period.
  Seah H. Lim, William V. Esler, Yana Zhang, Jian Zhang, Phillip O. Periman, Colleen Burris, Mary Townsend> ;Leukemia & Lymphoma. 2008 Jan 1
• 3 citations
  Risk of mistaken DNR orders
  James E. Rohrer, W. Vance Esler, Qaiser Saeed, Samreen Saeed, Phillip Periman, David Beggs, Paul Hancock, Seah H. Lim> ;Supportive Care in Cancer. 2006 Feb 9
• 20 citations
  Rituximab administration following autologous stem cell transplantation for multiple myeloma is associated with severe IgM deficiency.
  Seah H. Lim, Yana Zhang, Zhiqing Wang, Rupashree Varadarajan, Phillip Periman, W. Vance Esler> ;Blood. 2004 Mar 1
• 8 citations
  Defining tumor antigens: mRNA, protein or cytotoxicity?
  Seah H. Lim, Phillip Periman, Panpit Klug, Jon A. Weidanz, Vaughan Whitton, Maurizio Chiriva-Internati, Zhiqing Wang, Stephen E. Wright> ;Trends in Immunology. 2002 May 1
• 12 citations
  A phase II evaluation of all-trans-retinoic acid plus interferon alfa-2a in stage IV melanoma: a Southwest Oncology Group study.
  Vernon K. Sondak, P. Y. Liu, Lawrence E. Flaherty, William S. Fletcher, Phillip Periman, David R. Gandara, Sarah A. Taylor, Stanley P. Balcerzak, Frank L. Meyskens> ;The Cancer Journal from Scientific American. 1999 Jan 1
• 2 citations
  Double modulation of 5-fluorouracil in the treatment of advanced colorectal carcinoma: Report of a trial with sequential methotrexate, intravenous (loading dose) folin...
  Edward P. Balaban, Mateel Graham, Steve Perkins, Richard G. Sheehan, Eugene P. Frenkel, Michael Ross, Joan M C Bull, Brian T. Pruitt, Phillip Periman, Chris Ruud, Jame...> ;Cancer Investigation. 1994 Jan 1
• 347 citations
  Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemia
  Peter H. Wiernik, Phillip L.C. Banks, Delvyn C. Case, Zalmen A. Arlin, Phillip O. Periman, Mary B. Todd, Paul S. Ritch, Robert E. Enck, Alan B. Weitberg> ;Blood. 1992 Jan 15
• 101 citations
  Effectiveness of the cryosupernatant fraction of plasma in the treatment of refractory thrombotic thrombocytopenic purpura.
  John J. Byrnes, Joel L. Moake, Panpit Klug, Phillip Periman> ;American Journal of Hematology. 1990 Jul 1
• Vascular access for cancer chemotherapy.
  Periman P, Lane R, Cherni-Smith R, Pruitt BT> ;Tex Med. 1986-10-01
• 10 citations
  Hodgkin's disease occurring in a patient with the Wiskott-Aldrich syndrome.
  Phillip Periman, Thomas R. Callihan, Gerald W. King, Michael Blaese> ;Cancer. 1980 Jan 15
• 2 citations
  Delayed hypersensitivity reactions of cancer patients to antigens on lymphoid cell lines.
  Paul H. Levine, J. H. C. Ho, Francis K. Nkrumah, Phillip O. Periman, Nejib Mourali, G. B. Cannon, M. B. Middleton, I. V. Perkins, Ronald B. Herberman> ;International Journal of Cancer. 1978 Oct 15
• 13 citations
  Cell mediated immunity during infectious mononucleosis to Epstein-Barr virus associated antigens.
  Phillip O. Periman, Paul H. Levine, D. V. Ablashi, Ivor Royston> ;International Journal of Cancer. 1977 Oct 15
• 3 citations
  Cell-mediated immunity in acute infectious mononucleosis.
  Ivor Royston, Phillip O. Periman, > ;Bibliotheca Haematologica. 1976 Jan 1
• 85 citations
  Cell-Mediated Immunity to Epstein–Barr-Virus-Transformed Lymphoblastoid Cells in Acute Infectious Mononucleosis
  Ivor Royston, Phillip O. Periman, > ;The New England Journal of Medicine. 1975 Dec 4
• Comparative evaluation of two outpatient antiemetic regimens for cancer chemotherapy.
  Pruitt, B. T., Justice, R. L., Periman, P.> ;Tex Med. 1985 Jul 01
• The condom.
  Periman, P., Greene, M.> ;N Engl J Med. 1972 Nov 30
• Antibiotic-associated diarrhea.
  Periman, P.> ;N Engl J Med. 2002 Jul 11
• Reimbursement issues in clinical oncology.
  Vogelzang, N. J., Chabner, B. A., Periman, P., Ohrt, D. K., McCann, B. C., Burns, J. M., Bayer, R.> ;Semin Oncol. 1988 Dec
• Suicide among cancer patients.
  Periman, P.> ;J Clin Oncol. 1998 Jun
• Lymphocyte responses to EBV-associated antigens in infectious mononucleosis, and Hodgkin''s and non-Hodgkin''s lymphoma patients, with the leukocyte adherence inhibiti...
  Chan, S. H., Wallen, W. C., Levine, P. H., Periman, P., Perlin, E.> ;Int J Cancer. 1977 Mar 15
• Sunitinib malate for metastatic castration-resistant prostate cancer following docetaxel-based chemotherapy.
  Sonpavde, G., Periman, P. O., Bernold, D., Weckstein, D., Fleming, M. T., Galsky, M. D., Berry, W. R., Zhan, F., Boehm, K. A., Asmar, L., Hutson, T. E.> ;Ann Oncol. 2010 Feb 01
• Join now to see all